Main menu:
What is a Histologic Grade System?Histology is the study of tissues, including cellular structure and function. Pathologists (physicians who conduct laboratory studies of tissues and cells) often assign a histologic grade to a patients cancerous breast tumor to identify the type of tumor present and help determine the patients prognosis (projected outcome). The Scarff-Bloom-Richardson system is the most common type of cancer grade system used today. To determine a tumors histologic grade, pathologists examine the breast cancer cells and their patterns under a microscope. A sample of breast cells may be taken from a breast biopsy, lumpectomy or mastectomy. Pathologists closely observe three features when determining a cancers grade: the frequency of cell mitosis (rate of cell division), tubule formation (percentage of cancer composed of tubular structures), and nuclear pleomorphism (change in cell size and uniformity). Each of these features is assigned a score ranging from 1 to 3 (1 indicating slower cell growth and 3 indicating faster cell growth). The scores of each of the cells features are then added together for a final sum that will range between 3 to 9.
Courtesy of the American
Medical Association Summary of Histologic Grades of Breast Cancer A tumor with a final sum of 3, 4, or 5 is considered a Grade 1 tumor (well-differentiated). A sum of 6 or 7 is considered a Grade 2 tumor (moderately-differentiated), and a sum of 8 or 9 is a Grade 3 tumor (poorly-differentiated).
*Scarff-Bloom-Richardson grade system Pathologists also look for necrosis (areas of degenerating cancer cells) when determining a tumors grade. Cancers with a high grade, necrosis, cancers close to the surrounding margin of breast tissue of a lumpectomy sample, or large areas of DCIS are more likely to recur after breast cancer treatment than other breast cancers.(1) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Imaginis.com suscribes to the HONcode principles of the Health on the Net Foundation.
Copyright 1997-2009 Imaginis Corporation. All rights reserved. Imaginis® is a registered service mark of Imaginis Corporation, a health services company. All other trademarks and copyrights are property of their respective owners. Note: Use of this online service is subject to the disclaimer and the terms and conditions contained herein. Information found within the Imaginis.com website or in other sites linked to from Imaginis.com is provided for educational purposes only and is not intended to be used as a substitute for diagnosis and treatment by a medical doctor. Imaginis does not endorse and has no responsibility for the content of any other sites listed on Imaginis.com, and provides links and references merely as a convenience to its users. Seek immediate medical attention if your condition is urgent. Imaginis - The Breast Cancer Resource